Bruush Oral Care Stock Cash Per Share
| BRSHDelisted Stock | USD 0.0005 0.0001 16.67% |
Bruush Oral Care fundamentals help investors to digest information that contributes to Bruush Oral's financial success or failures. It also enables traders to predict the movement of Bruush Stock. The fundamental analysis module provides a way to measure Bruush Oral's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bruush Oral stock.
Bruush |
Bruush Oral Care Company Cash Per Share Analysis
Bruush Oral's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
CompetitionIn accordance with the recently published financial statements, Bruush Oral Care has a Cash Per Share of 0.0 times. This is 100.0% lower than that of the Personal Care Products sector and 100.0% lower than that of the Consumer Staples industry. The cash per share for all United States stocks is 100.0% higher than that of the company.
Bruush Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bruush Oral's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bruush Oral could also be used in its relative valuation, which is a method of valuing Bruush Oral by comparing valuation metrics of similar companies.Bruush Oral is currently under evaluation in cash per share category among its peers.
Bruush Fundamentals
| Return On Asset | -5.77 | |||
| Profit Margin | (2.57) % | |||
| Operating Margin | (5.29) % | |||
| Current Valuation | 2.51 M | |||
| Shares Outstanding | 100.97 M | |||
| Shares Owned By Insiders | 17.35 % | |||
| Shares Owned By Institutions | 12.96 % | |||
| Number Of Shares Shorted | 2.22 M | |||
| Price To Sales | 2.97 X | |||
| Revenue | 2.63 M | |||
| Gross Profit | 1.76 M | |||
| EBITDA | (10.49 M) | |||
| Net Income | (8.77 M) | |||
| Total Debt | 2.59 M | |||
| Current Ratio | 0.21 X | |||
| Book Value Per Share | (10.12) X | |||
| Cash Flow From Operations | (12.59 M) | |||
| Short Ratio | 0.05 X | |||
| Earnings Per Share | (14.67) X | |||
| Number Of Employees | 11 | |||
| Market Capitalization | 8.68 M | |||
| Total Asset | 1.19 M | |||
| Retained Earnings | (26.39 M) | |||
| Working Capital | (1.41 M) | |||
| Net Asset | 1.19 M |
About Bruush Oral Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bruush Oral Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bruush Oral using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bruush Oral Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Bruush Stock
If you are still planning to invest in Bruush Oral Care check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bruush Oral's history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |